dc.contributor.author | Abuga, KO | |
dc.contributor.author | Mwagiru, PM | |
dc.contributor.author | Thoithi, GN | |
dc.contributor.author | Nguyo, JM | |
dc.contributor.author | Ngugi, JK | |
dc.contributor.author | King'ondu, OK | |
dc.contributor.author | Mugo, HN | |
dc.contributor.author | Kibwage, IO | |
dc.date.accessioned | 2013-02-20T08:08:23Z | |
dc.date.issued | 2003 | |
dc.identifier.citation | East and Central African journal of pharmaceutical sciences Vol. 6(2003) 20-23 | en |
dc.identifier.uri | http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/10413 | |
dc.description.abstract | During the period 2000-2003 the Drug Analysis and Research Unit received and analyzed 33 samples of antiretroviral drugs. Locally manufactured products accounted for 57.6 % of the samples, while the imported drugs constituted 42.4 %. The drugs consisted of single, double and triple component preparations. They were subjected to the identity, assay and dissolution tests. 30 samples (90.9 %) complied with compedial specifications for these tests, while 3 failed. The results obtained show that manufacture of quality generic antiretroviral drugs is achievable. | en |
dc.language.iso | en | en |
dc.subject | Antiretroviral, | en |
dc.subject | Assay, | en |
dc.subject | Dissolution, | en |
dc.subject | Nucleoside, | en |
dc.subject | reverse-transcriptase inhibitor | en |
dc.title | Quality of antiretroviral drugs analyzed in the drug analysis and research unit during 2000--2003 | en |
dc.type | Article | en |